{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:12:44Z","timestamp":1773425564507,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.npep.2021.102184","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:03:47Z","timestamp":1629205427000},"page":"102184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Chronic oral nicotine administration and withdrawal regulate the expression of neuropeptide Y and its receptors in the mesocorticolimbic system"],"prefix":"10.1016","volume":"90","author":[{"given":"Ali","family":"Birdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Salur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulya","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan C.","family":"Gokmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha","family":"Ozturk Bintepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buket","family":"Aypar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Keser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersin O.","family":"Koylu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfiye","family":"Kanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguz","family":"Gozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2021.102184_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-4328(00)00208-4","article-title":"Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance","volume":"113","author":"Albuquerque","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ejn.13233","article-title":"Involvement of serotonin 2C receptor RNA editing in accumbal neuropeptide Y expression and behavioural despair","volume":"43","author":"Aoki","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbr.2011.03.067","article-title":"Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype","volume":"222","author":"Aydin","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0020","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.peptides.2006.07.020","article-title":"Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze","volume":"27","author":"Bacchi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102184_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198307213090303","article-title":"Smokers of low-yield cigarettes do not consume less nicotine","volume":"309","author":"Benowitz","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.npep.2021.102184_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(99)00234-7","article-title":"Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression","volume":"265","author":"Caberlotto","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102184_bb0045","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1016\/S0014-2999(99)00843-2","article-title":"Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine","volume":"387","author":"Cadoni","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2017.06.012","article-title":"Access to nicotine in drinking water reduces weight gain without changing caloric intake on high fat diet in male C57BL\/6J mice","volume":"123","author":"Calarco","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0055","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nn.4101","article-title":"Resolving the neural circuits of anxiety","volume":"18","author":"Calhoon","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbr.2010.08.044","article-title":"Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice","volume":"216","author":"Christiansen","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.alcohol.2010.09.003","article-title":"The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety","volume":"45","author":"Cippitelli","year":"2011","journal-title":"Alcohol"},{"key":"10.1016\/j.npep.2021.102184_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jnr.1092","article-title":"Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions","volume":"64","author":"Clausen","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2021.102184_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cne.903000312","article-title":"Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus","volume":"300","author":"Deller","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/30001","article-title":"Dramatic decreases in brain reward function during nicotine withdrawal","volume":"393","author":"Epping-Jordan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.npep.2021.102184_bb0085","doi-asserted-by":"crossref","first-page":"216464","DOI":"10.4061\/2011\/216464","article-title":"Modulation of tyrosine hydroxylase, neuropeptide y, glutamate, and substance p in Ganglia and brain areas involved in cardiovascular control after chronic exposure to nicotine","volume":"2011","author":"Ferrari","year":"2011","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.npep.2021.102184_bb0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(95)00834-D","article-title":"Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine\u2019s effects on energy balance","volume":"694","author":"Frankish","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I","article-title":"Interneurons of the hippocampus","volume":"6","author":"Freund","year":"1996","journal-title":"Hippocampus"},{"key":"10.1016\/j.npep.2021.102184_bb0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.neuron.2008.01.034","article-title":"Ivy cells: a population of nitric-oxide-producing, slow-spiking GABAergic neurons and their involvement in hippocampal network activity","volume":"57","author":"Fuentealba","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2021.102184_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-4328(00)00201-1","article-title":"Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice","volume":"113","author":"Gaddnas","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0110","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2011.02.004","article-title":"Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence","volume":"69","author":"Gilpin","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102184_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00213-004-2007-3","article-title":"Nicotine physical dependence and tolerance in the mouse following chronic oral administration","volume":"178","author":"Grabus","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0306-4522(00)00308-0","article-title":"Neuropeptide Y Y5 receptor protein in the cortical\/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons","volume":"100","author":"Grove","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2021.102184_bb0125","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","article-title":"Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys","volume":"109","author":"Huang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2021.102184_bb0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00008877-199911000-00016","article-title":"Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine","volume":"10","author":"Irvine","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(00)00449-4","article-title":"Tolerance to nicotine\u2019s effects in the elevated plus-maze and increased anxiety during withdrawal","volume":"68","author":"Irvine","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102184_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hipo.20264","article-title":"Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor","volume":"17","author":"Ishida","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.npep.2021.102184_bb0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0945-2","article-title":"The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice","volume":"195","author":"Karlsson","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(95)98374-8","article-title":"Striatal interneurones: chemical, physiological and morphological characterization","volume":"18","author":"Kawaguchi","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2014.11.044","article-title":"The dark side of emotion: the addiction perspective","volume":"753","author":"Koob","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4522(01)00463-8","article-title":"Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization","volume":"111","author":"Kopp","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2021.102184_bb0165","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cercor\/bhq252","article-title":"Selective coexpression of multiple chemical markers defines discrete populations of neocortical GABAergic neurons","volume":"21","author":"Kubota","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.npep.2021.102184_bb0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(00)02283-6","article-title":"Nicotine administration enhances NPY expression in the rat hypothalamus","volume":"867","author":"Li","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/978-3-540-69248-5_14","article-title":"Rodent models of nicotine withdrawal syndrome","author":"Malin","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0180","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0091-3057(92)90408-8","article-title":"Rodent model of nicotine abstinence syndrome","volume":"43","author":"Malin","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102184_bb0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuint.2006.03.010","article-title":"Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke","volume":"49","author":"Mannucci","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.npep.2021.102184_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2008.06.023","article-title":"Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats","volume":"194","author":"Maric","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0195","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.peptides.2008.11.006","article-title":"Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats","volume":"30","author":"Maric","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102184_bb0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0205","doi-asserted-by":"crossref","first-page":"107804","DOI":"10.1016\/j.neuropharm.2019.107804","article-title":"Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD","volume":"162","author":"Maymon","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(89)90659-9","article-title":"Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala","volume":"100","author":"McDonald","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102184_bb0215","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1523\/JNEUROSCI.2621-19.2020","article-title":"Contribution of NPY Y5 receptors to the reversible structural remodeling of basolateral amygdala dendrites in male rats associated with NPY-mediated stress resilience","volume":"40","author":"Michaelson","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2012.05.015","article-title":"The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat","volume":"233","author":"Morales-Medina","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y(1) and Y(2) receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:29:2:109","article-title":"Distribution of NPY Y5-like immunoreactivity in the rat brain","volume":"29","author":"Morin","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.902900305","article-title":"Neuronal localisation of neuropeptide Y gene expression in rat brain","volume":"290","author":"Morris","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0196-9781(97)00298-2","article-title":"Neuropeptide Y produces anxiety via Y2-type receptors","volume":"19","author":"Nakajima","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102184_bb0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<369::AID-SYN8>3.0.CO;2-9","article-title":"Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat","volume":"22","author":"Nisell","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2021.102184_bb0250","doi-asserted-by":"crossref","first-page":"102001","DOI":"10.1016\/j.npep.2019.102001","article-title":"Activation of NPY receptor subtype 1 by [D-his(26)]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD","volume":"80","author":"Nwokafor","year":"2020","journal-title":"Neuropeptides"},{"issue":"Pt B","key":"10.1016\/j.npep.2021.102184_bb0255","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neuropharm.2013.04.055","article-title":"A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females","volume":"76","author":"O'Dell","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jnr.22770","article-title":"Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice","volume":"90","author":"Olesen","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2021.102184_bb0265","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1460-9568.1999.00553.x","article-title":"Regional distribution of Y-receptor subtype mRNAs in rat brain","volume":"11","author":"Parker","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0270","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.npep.2021.102184_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.105","article-title":"Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal","volume":"3","author":"Perez","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.npep.2021.102184_bb0280","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1523\/JNEUROSCI.0026-18.2018","article-title":"Choice for drug or natural reward engages largely overlapping neuronal ensembles in the infralimbic prefrontal cortex","volume":"38","author":"Pfarr","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0285","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.npep.2021.102184_bb0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jnr.23858","article-title":"Sex differences in nicotine preference","volume":"95","author":"Pogun","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2021.102184_bb0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tics.2011.12.011","article-title":"Neural circuits underlying the pathophysiology of mood disorders","volume":"16","author":"Price","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.npep.2021.102184_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.25","article-title":"Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal","volume":"4","author":"Qi","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.npep.2021.102184_bb0305","doi-asserted-by":"crossref","first-page":"12967","DOI":"10.1523\/JNEUROSCI.4297-06.2006","article-title":"Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress","volume":"26","author":"Radley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0310","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.neuroscience.2019.04.047","article-title":"Sex differences in neuroplasticity- and stress-related gene expression and protein levels in the rat hippocampus following oxycodone conditioned place preference","volume":"410","author":"Randesi","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2021.102184_bb0315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.peptides.2012.01.004","article-title":"Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease","volume":"33","author":"Rangani","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102184_bb0320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: a stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102184_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2004.10.084","article-title":"Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence","volume":"375","author":"Rimondini","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2021.102184_bb0335","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41386-018-0310-7","article-title":"Medial prefrontal cortex neuropeptide Y modulates binge-like ethanol consumption in C57BL\/6J mice","volume":"44","author":"Robinson","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0340","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/cne.22143","article-title":"Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala","volume":"517","author":"Rostkowski","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0196-9781(98)00139-9","article-title":"Sex differences in neuropeptide distribution in the rat brain","volume":"20","author":"Rugarn","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2021.102184_bb0350","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.npep.2008.03.004","article-title":"Effects of NPY and the specific Y1 receptor agonist [D-his(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats","volume":"42","author":"Rylkova","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102184_bb0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.npep.2015.11.004","article-title":"Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder","volume":"56","author":"Sabban","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102184_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.7","article-title":"NPY+-, but not PV+- GABAergic neurons mediated long-range inhibition from infra- to prelimbic cortex","volume":"6","author":"Saffari","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.npep.2021.102184_bb0365","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0370","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cne.902900205","article-title":"Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin","volume":"290","author":"Sesack","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0375","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/sj.npp.1301258","article-title":"The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y","volume":"32","author":"Smialowska","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2021.102184_bb0380","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"Sorensen","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2021.102184_bb0385","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pbb.2013.02.010","article-title":"Neuropeptide Y Y5 receptor antagonism causes faster extinction and attenuates reinstatement in cocaine-induced place preference","volume":"105","author":"Sorensen","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2021.102184_bb0390","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2007.04.001","article-title":"Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY)","volume":"90","author":"Sparta","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.npep.2021.102184_bb0395","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stanic","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0400","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2021.102184_bb0405","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.npep.2015.09.007","article-title":"The role of neuropeptide Y in fear conditioning and extinction","volume":"55","author":"Tasan","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2021.102184_bb0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fendo.2017.00178","article-title":"Neuropeptide Y in alcohol addiction and affective disorders","volume":"8","author":"Thorsell","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.npep.2021.102184_bb0415","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.220232997","article-title":"Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression","volume":"97","author":"Thorsell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2021.102184_bb0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2005.01.016","article-title":"Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure","volume":"161","author":"Thorsell","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2021.102184_bb0425","first-page":"71","article-title":"Chronic nicotine-induced changes in gene expression of delta and kappa-opioid receptors and their endogenous ligands in the mesocorticolimbic system of the rat","author":"Ugur","year":"2017","journal-title":"Synapse"},{"key":"10.1016\/j.npep.2021.102184_bb0430","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2014.06.008","article-title":"Neuropeptide Y activity in the nucleus accumbens modulates feeding behavior and neuronal activity","volume":"77","author":"van den Heuvel","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2021.102184_bb0435","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1523\/JNEUROSCI.4955-13.2016","article-title":"Neuropeptide Y impairs retrieval of extinguished fear and modulates excitability of neurons in the infralimbic prefrontal cortex","volume":"36","author":"Vollmer","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2021.102184_bb0440","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","article-title":"The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]me thyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity","volume":"328","author":"Walker","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102184_bb0445","doi-asserted-by":"crossref","first-page":"7898095","DOI":"10.1155\/2019\/7898095","article-title":"NPY receptor 2 mediates NPY antidepressant effect in the mPFC of LPS rat by suppressing NLRP3 signaling pathway","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.npep.2021.102184_bb0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cne.10823","article-title":"Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry","volume":"464","author":"Wolak","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0455","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(24)37249-0","article-title":"Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors","volume":"284","author":"Woldbye","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2021.102184_bb0460","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/alcalc\/37.4.318","article-title":"Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y","volume":"37","author":"Woldbye","year":"2002","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.npep.2021.102184_bb0465","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s00429-015-1107-7","article-title":"Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala","volume":"221","author":"Wood","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.npep.2021.102184_bb0470","doi-asserted-by":"crossref","first-page":"113216","DOI":"10.1016\/j.expneurol.2020.113216","article-title":"Neuropeptide Y neurons in the nucleus accumbens modulate anxiety-like behavior","volume":"327","author":"Yamada","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2021.102184_bb0475","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1530-0277.2009.01109.x","article-title":"Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats","volume":"34","author":"Zhang","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417921000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:37:54Z","timestamp":1758919074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417921000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":95,"alternative-id":["S0143417921000706"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2021.102184","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic oral nicotine administration and withdrawal regulate the expression of neuropeptide Y and its receptors in the mesocorticolimbic system","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2021.102184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102184"}}